×

AAK1 cDNA ORF clone, Homo sapiens(Human)

Gene Symbol AAK1
Entrez Gene ID 22848
Full Name AP2 associated kinase 1
General protein information
Preferred Names

AP2 associated kinase 1

Names

AP2-associated protein kinase 1
adaptor-associated kinase 1

Gene Type protein-coding
Organism Homo sapiens(Human)
Genome

2

2p13.3

Summary Adaptor-related protein complex 2 (AP-2 complexes) functions during receptor-mediated endocytosis to trigger clathrin assembly, interact with membrane-bound receptors, and recruit encodytic accessory factors. This gene encodes a member of the SNF1 subfamily of Ser/Thr protein kinases. The protein interacts with and phosphorylates a subunit of the AP-2 complex, which promotes binding of AP-2 to sorting signals found in membrane-bound receptors and subsequent receptor endocytosis. Its kinase activity is stimulated by clathrin. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008].
Disorder MIM:

616405


mRNA and Protein(s)

mRNA Protein Name
NM_014911.3 NP_055726.3 AP2-associated protein kinase 1



Pan troglodytes (chimpanzee) AAK1 XP_001138187.3
Rattus norvegicus (Norway rat) Aak1 NP_001166921.1
Homo sapiens (human) AAK1 NP_055726.3
Gallus gallus (chicken) AAK1 XP_417663.4
Canis lupus familiaris (dog) AAK1 XP_005626238.1
Mus musculus (house mouse) Aak1 NP_001035195.1


Related articles in PubMed

Family-wide Structural Analysis of Human Numb-Associated Protein Kinases.
Sorrell FJ, Szklarz M, Abdul Azeez KR, Elkins JM, Knapp S
Structure (London, England : 1993)24(3)401-11(2016 Mar)

Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy.
So J, Pasculescu A, Dai AY, Williton K, James A, Nguyen V, Creixell P, Schoof EM, Sinclair J, Barrios-Rodiles M, Gu J, Krizus A, Williams R, Olhovsky M, Dennis JW, Wrana JL, Linding R, Jorgensen C, Pawson T, Colwill K
Science signaling8(371)rs3(2015 Apr)

AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets.
Neveu G, Ziv-Av A, Barouch-Bentov R, Berkerman E, Mulholland J, Einav S
Journal of virology89(8)4387-404(2015 Apr)

Genetic variants associated with serum thyroid stimulating hormone (TSH) levels in European Americans and African Americans from the eMERGE Network.
Malinowski JR, Denny JC, Bielinski SJ, Basford MA, Bradford Y, Peissig PL, Carrell D, Crosslin DR, Pathak J, Rasmussen L, Pacheco J, Kho A, Newton KM, Li R, Kullo IJ, Chute CG, Chisholm RL, Jarvik GP, Larson EB, McCarty CA, Masys DR, Roden DM, de Andrade M, Ritchie MD, Crawford DC
PloS one9(12)e111301(2014)

Genome-wide association study of a heart failure related metabolomic profile among African Americans in the Atherosclerosis Risk in Communities (ARIC) study.
Yu B, Zheng Y, Alexander D, Manolio TA, Alonso A, Nettleton JA, Boerwinkle E
Genetic epidemiology37(8)840-5(2013 Dec)

GeneRIFs: Gene References Into Functions What's a GeneRIF?

Results present the first structures of AAK1 and BIKE which reveal that all members of the Numb-associated kinase family share unusual activation segment architecture.
Title: Family-wide Structural Analysis of Human Numb-Associated Protein Kinases.

Two of these kinases that were classified as resistors were PX domain-containing serine/threonine kinase (PXK) and AP2-associated kinase 1 (AAK1), which promote receptor endocytosis and may enable cells to resist TRAIL-induced apoptosis
Title: Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy.

AAK1 and GAK are critical regulators of HCV entry that function in part by activating EGFR, AP2M1, and NUMB, and as the molecular targets underlying the antiviral effect of sunitinib and erlotinib, respectively.
Title: AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets.

AAK1 increases the localization of activated Notch to Rab5-positive endocytic vesicles, while AAK1 depletion or overexpression of Numb, an inhibitor of the pathway, interferes with this localization.
Title: The adaptor-associated kinase 1, AAK1, is a positive regulator of the Notch pathway.

Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)
Title: Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.

The following AAK1 gene cDNA ORF clone sequences were retrieved from the NCBI Reference Sequence Database (RefSeq). These sequences represent the protein coding region of the AAK1 cDNA ORF which is encoded by the open reading frame (ORF) sequence. ORF sequences can be delivered in our standard vector, pcDNA3.1+/C-(K)DYK or the vector of your choice as an expression/transfection-ready ORF clone. Not the clone you want? Click here to find your clone.

Online Only Promotion

Up to 50% OFF! Starting
from $49/clone

***CloneID RefSeq Accession Definition **Vector *Turnaround time Price (USD) Select
OHu25045 NM_014911.3
Latest version!
Homo sapiens AP2 associated kinase 1 (AAK1), mRNA. pcDNA3.1+/C-(K)DYK or customized vector 12-14 $475.30
$679.00

ORF Online Only Promotion

Next-day Shipping ORF Clones ( in default vector with tag)
1 Clone 30% OFF
2-4 Clone 40% OFF
5 or more Clone 50% OFF
All Other ORF Clones
30% OFF

*Business Day

** You may select a custom vector to replace pcDNA3.1+/C-(K)DYK after clone is added to cart.

** GenScript guarantees 100% sequence accuracy of all synthetic DNA constructs we deliver, but we do not guarantee protein expression in your experimental system. Protein expression is influenced by many factors that may vary between experiments or laboratories. In addition, please pay attention to the signal peptide, propeptide and transit peptide in target ORF, which may affect the choice of vector (N/C terminal tag vector).

***One clone ID might be correlated to multiple accession numbers, which share the same CDS sequence.


CloneID OHu25045
Clone ID Related Accession (Same CDS sequence) NM_014911.3
Accession Version NM_014911.3 Latest version! Documents for ORF clone product in dufault vector
Sequence Information ORF Nucleotide Sequence (Length: 2886bp)
Protein sequence
SNP
Vector pcDNA3.1+/C-(K)DYK or customized vector User Manual
Clone information Clone Map MSDS
Tag on pcDNA3.1+/C-(K)DYK C terminal DYKDDDDK tags
ORF Insert Method CloneEZ® Seamless cloning technology
Insert Structure linear
Update Date 2017-04-17
Organism Homo sapiens(Human)
Product AP2-associated protein kinase 1
Comment REVIEWED REFSEQ: This record has been curated by NCBI staff. The reference sequence was derived from AW451954.1, DB285703.1, BC111965.1, DA121999.1, AW969393.1, AC136007.3, AC114772.5 and CA436375.1. On or before May 25, 2007 this sequence version replaced XM_930257.2, XM_941900.2, NM_014911.2. Sequence Note: This RefSeq record was created from transcript and genomic sequence data because no single transcript was available for the full length of the gene. The extent of this transcript is supported by transcript alignments. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## RNAseq introns :: mixed/partial sample support SAMEA1965299, SAMEA1966682 [ECO:0000350] ##Evidence-Data-END## ##RefSeq-Attributes-START## inferred exon combination :: based on alignments, homology ##RefSeq-Attributes-END## COMPLETENESS: complete on the 3' end.

1
61
121
181
241
301
361
421
481
541
601
661
721
781
841
901
961
1021
1081
1141
1201
1261
1321
1381
1441
1501
1561
1621
1681
1741
1801
1861
1921
1981
2041
2101
2161
2221
2281
2341
2401
2461
2521
2581
2641
2701
2761
2821
2881
ATGAAGAAGT TTTTCGACTC CCGGCGAGAG CAGGGCGGCT CTGGCCTGGG CTCCGGCTCC 
AGCGGAGGAG GGGGCAGCAC CTCGGGCCTG GGCAGTGGCT ACATCGGAAG AGTCTTCGGC
ATCGGGCGAC AGCAGGTCAC AGTGGACGAG GTGTTGGCGG AAGGTGGATT TGCTATTGTA
TTTCTGGTGA GGACAAGCAA TGGGATGAAA TGTGCCTTGA AACGCATGTT TGTCAACAAT
GAGCATGATC TCCAGGTGTG CAAGAGAGAA ATCCAGATAA TGAGGGATCT TTCAGGGCAC
AAGAATATTG TGGGTTACAT TGATTCTAGT ATCAACAACG TGAGTAGCGG TGATGTATGG
GAAGTGCTCA TTCTGATGGA CTTTTGTAGA GGTGGCCAGG TGGTAAACCT GATGAACCAG
CGCCTGCAAA CAGGCTTTAC AGAGAATGAA GTGCTCCAGA TATTTTGTGA TACCTGTGAA
GCTGTTGCCC GCCTGCATCA GTGCAAAACT CCTATTATCC ACCGGGACCT GAAGGTTGAA
AACATCCTCT TGCATGACCG AGGCCACTAT GTCCTGTGTG ACTTTGGAAG CGCCACCAAC
AAATTCCAGA ATCCACAAAC TGAGGGAGTC AATGCAGTAG AAGATGAGAT TAAGAAATAC
ACAACGCTGT CCTATCGAGC ACCAGAAATG GTCAACCTGT ACAGTGGCAA AATCATCACT
ACGAAGGCAG ACATTTGGGC TCTTGGATGT TTGTTGTATA AATTATGCTA CTTCACTTTG
CCATTTGGGG AAAGTCAGGT GGCAATTTGT GATGGAAACT TCACAATTCC TGATAATTCT
CGATATTCTC AAGACATGCA CTGCCTAATT AGGTATATGT TGGAACCAGA CCCTGACAAA
AGGCCGGATA TTTACCAGGT GTCCTACTTC TCATTTAAGC TACTCAAGAA AGAGTGCCCA
ATTCCAAATG TACAGAACTC TCCCATTCCT GCAAAGCTTC CTGAACCAGT GAAAGCCAGT
GAGGCAGCTG CAAAAAAGAC CCAGCCAAAG GCCAGACTGA CAGATCCCAT TCCCACCACA
GAGACTTCAA TTGCACCCCG CCAGAGGCCT AAAGCTGGGC AGACTCAGCC GAACCCAGGA
ATCCTTCCCA TCCAGCCAGC GCTGACACCC CGGAAGAGGG CCACTGTTCA GCCCCCACCT
CAGGCTGCAG GATCCAGCAA TCAGCCTGGC CTTTTAGCCA GTGTTCCCCA ACCAAAACCC
CAAGCCCCAC CCAGCCAGCC TCTGCCGCAA ACTCAGGCCA AGCAGCCACA GGCTCCTCCC
ACTCCACAGC AGACGCCTTC TACTCAGGCC CAGGGTCTGC CCGCTCAGGC CCAGGCCACA
CCCCAGCACC AGCAGCAACT CTTCCTCAAG CAGCAACAGC AGCAGCAACA GCCACCGCCA
GCACAGCAGC AGCCGGCAGG CACGTTTTAC CAGCAGCAGC AGGCCCAGAC TCAGCAGTTT
CAGGCAGTAC ATCCAGCAAC CCAGCAACCA GCAATTGCTC AGTTCCCTGT GGTGTCCCAA
GGAGGCTCTC AACAGCAGCT AATGCAGAAT TTCTACCAGC AGCAGCAGCA GCAGCAACAA
CAACAGCAAC AGCAACAGCT GGCCACAGCC CTGCATCAAC AACAGCTGAT GACTCAGCAG
GCTGCCTTGC AGCAAAAGCC CACTATGGCA GCAGGACAGC AGCCCCAGCC ACAGCCAGCT
GCAGCCCCAC AGCCAGCCCC TGCCCAGGAG CCAGCGATTC AAGCCCCAGT AAGACAACAG
CCAAAGGTTC AGACAACCCC ACCTCCTGCC GTCCAGGGGC AGAAAGTTGG ATCTCTCACT
CCACCCTCAT CCCCCAAAAC CCAACGTGCT GGGCACAGGC GTATTCTCAG TGACGTAACC
CACAGTGCAG TCTTTGGGGT CCCTGCCAGC AAATCAACCC AGCTGCTCCA GGCAGCTGCA
GCTGAGGCCA GTCTCAATAA GTCCAAGTCT GCAACCACCA CTCCATCAGG CTCTCCTCGG
ACCTCTCAAC AAAACGTTTA TAATCCTTCA GAAGGGTCTA CGTGGAATCC CTTTGATGAC
GATAATTTCT CCAAACTCAC AGCTGAAGAA CTGCTAAACA AGGACTTTGC CAAGCTTGGG
GAAGGCAAAC ATCCCGAGAA GCTTGGAGGC TCAGCTGAGA GTTTGATCCC AGGCTTTCAA
TCAACCCAAG GTGATGCTTT TGCTACGACC TCATTTTCTG CTGGAACTGC TGAAAAAAGG
AAGGGTGGGC AGACTGTGGA CTCTGGCCTC CCGCTTCTAA GCGTGTCTGA TCCTTTCATT
CCTCTTCAAG TACCTGATGC ACCAGAAAAA CTAATTGAGG GACTCAAATC TCCTGACACT
TCTCTTCTGC TCCCTGACCT CTTGCCTATG ACAGATCCTT TTGGTAGCAC TTCTGATGCT
GTAATTGAAA AAGCTGATGT TGCTGTTGAG AGTCTCATAC CAGGACTGGA GCCCCCAGTT
CCCCAGCGCC TCCCATCTCA GACGGAATCT GTGACCTCGA ATCGCACAGA TTCTCTCACC
GGGGAAGATT CCCTGCTTGA TTGCTCTCTG CTCTCTAACC CTACTACTGA CCTTCTGGAA
GAGTTTGCCC CCACAGCAAT CTCTGCTCCA GTCCATAAAG CTGCAGAAGA TAGTAATCTC
ATCTCAGGTT TTGATGTCCC TGAGGGCTCG GACAAGGTGG CTGAAGATGA GTTTGACCCT
ATTCCTGTAT TGATAACCAA AAACCCACAA GGTGGGCACT CTAGAAACAG CAGTGGGAGC
TCTGAGTCCA GTCTTCCCAA CCTAGCCAGG TCTTTACTGC TGGTGGATCA GCTCATAGAC
CTGTAG

The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

RefSeq NP_055726.3
CDS506..3391
Misc Feature(1)401..403
Misc Feature(2)506..508
Misc Feature(3)545..547
Misc Feature(4)629..1453
Misc Feature(5)644..1426
Misc Feature(6)order(659..673,683..685,719..721,725..727,815..817,881..892,902..904,908..910,1031..1033,1037..1039,1043..1048,1052..1054,1085..1087,1094..1096,1166..1177)
Misc Feature(7)order(659..673,683..685,719..721,725..727,815..817,881..892,902..904,1031..1033,1037..1039,1043..1048,1052..1054,1085..1087)
Misc Feature(8)order(671..673,902..904,908..910,1031..1033,1037..1039,1043..1045,1094..1096,1166..1177)
Misc Feature(9)order(1082..1126,1127..1177)
Misc Feature(10)1205..1207
Misc Feature(11)1208..1210
Misc Feature(12)1565..1567
Misc Feature(13)1670..1672
Misc Feature(14)1676..1678
Misc Feature(15)1826..1828
Misc Feature(16)2321..2323
Misc Feature(17)2321..2323
Misc Feature(18)2357..2359
Misc Feature(19)2363..2365
Misc Feature(20)2363..2365
Misc Feature(21)2372..2374
Misc Feature(22)2372..2374
Misc Feature(23)2375..2377
Misc Feature(24)2375..2377
Misc Feature(25)2414..2416
Misc Feature(26)2453..2455
Misc Feature(27)2462..2464
Misc Feature(28)2564..2566
Misc Feature(29)2696..2698
Misc Feature(30)3041..3043
Misc Feature(31)3314..3316
Misc Feature(32)3317..3319
Exon (1)1..271
Exon (2)272..668
Exon (3)669..787
Exon (4)788..896
Exon (5)897..1039
Exon (6)1040..1161
Exon (7)1162..1243
Exon (8)1244..1376
Exon (9)1377..1480
Exon (10)1481..1560
Exon (11)1561..1715
Exon (12)1716..2002
Exon (13)2003..2281
Exon (14)2282..2511
Exon (15)2512..2669
Exon (16)2670..2774
Exon (17)2775..2870
Exon (18)2871..2972
Exon (19)2973..3074
Exon (20)3075..3185
Exon (21)3186..3296
Exon (22)3297..21265
Translation

Target ORF information:

RefSeq Version NM_014911.3
Organism Homo sapiens(Human)
Definition Homo sapiens AP2 associated kinase 1 (AAK1), mRNA.

Target ORF information:

Epitope DYKDDDDK
Bacterial selection AMPR
Mammalian selection NeoR
Vector pcDNA3.1+/C-(K)DYK
NM_014911.3

ORF Insert Sequence:

1
61
121
181
241
301
361
421
481
541
601
661
721
781
841
901
961
1021
1081
1141
1201
1261
1321
1381
1441
1501
1561
1621
1681
1741
1801
1861
1921
1981
2041
2101
2161
2221
2281
2341
2401
2461
2521
2581
2641
2701
2761
2821
2881
ATGAAGAAGT TTTTCGACTC CCGGCGAGAG CAGGGCGGCT CTGGCCTGGG CTCCGGCTCC 
AGCGGAGGAG GGGGCAGCAC CTCGGGCCTG GGCAGTGGCT ACATCGGAAG AGTCTTCGGC
ATCGGGCGAC AGCAGGTCAC AGTGGACGAG GTGTTGGCGG AAGGTGGATT TGCTATTGTA
TTTCTGGTGA GGACAAGCAA TGGGATGAAA TGTGCCTTGA AACGCATGTT TGTCAACAAT
GAGCATGATC TCCAGGTGTG CAAGAGAGAA ATCCAGATAA TGAGGGATCT TTCAGGGCAC
AAGAATATTG TGGGTTACAT TGATTCTAGT ATCAACAACG TGAGTAGCGG TGATGTATGG
GAAGTGCTCA TTCTGATGGA CTTTTGTAGA GGTGGCCAGG TGGTAAACCT GATGAACCAG
CGCCTGCAAA CAGGCTTTAC AGAGAATGAA GTGCTCCAGA TATTTTGTGA TACCTGTGAA
GCTGTTGCCC GCCTGCATCA GTGCAAAACT CCTATTATCC ACCGGGACCT GAAGGTTGAA
AACATCCTCT TGCATGACCG AGGCCACTAT GTCCTGTGTG ACTTTGGAAG CGCCACCAAC
AAATTCCAGA ATCCACAAAC TGAGGGAGTC AATGCAGTAG AAGATGAGAT TAAGAAATAC
ACAACGCTGT CCTATCGAGC ACCAGAAATG GTCAACCTGT ACAGTGGCAA AATCATCACT
ACGAAGGCAG ACATTTGGGC TCTTGGATGT TTGTTGTATA AATTATGCTA CTTCACTTTG
CCATTTGGGG AAAGTCAGGT GGCAATTTGT GATGGAAACT TCACAATTCC TGATAATTCT
CGATATTCTC AAGACATGCA CTGCCTAATT AGGTATATGT TGGAACCAGA CCCTGACAAA
AGGCCGGATA TTTACCAGGT GTCCTACTTC TCATTTAAGC TACTCAAGAA AGAGTGCCCA
ATTCCAAATG TACAGAACTC TCCCATTCCT GCAAAGCTTC CTGAACCAGT GAAAGCCAGT
GAGGCAGCTG CAAAAAAGAC CCAGCCAAAG GCCAGACTGA CAGATCCCAT TCCCACCACA
GAGACTTCAA TTGCACCCCG CCAGAGGCCT AAAGCTGGGC AGACTCAGCC GAACCCAGGA
ATCCTTCCCA TCCAGCCAGC GCTGACACCC CGGAAGAGGG CCACTGTTCA GCCCCCACCT
CAGGCTGCAG GATCCAGCAA TCAGCCTGGC CTTTTAGCCA GTGTTCCCCA ACCAAAACCC
CAAGCCCCAC CCAGCCAGCC TCTGCCGCAA ACTCAGGCCA AGCAGCCACA GGCTCCTCCC
ACTCCACAGC AGACGCCTTC TACTCAGGCC CAGGGTCTGC CCGCTCAGGC CCAGGCCACA
CCCCAGCACC AGCAGCAACT CTTCCTCAAG CAGCAACAGC AGCAGCAACA GCCACCGCCA
GCACAGCAGC AGCCGGCAGG CACGTTTTAC CAGCAGCAGC AGGCCCAGAC TCAGCAGTTT
CAGGCAGTAC ATCCAGCAAC CCAGCAACCA GCAATTGCTC AGTTCCCTGT GGTGTCCCAA
GGAGGCTCTC AACAGCAGCT AATGCAGAAT TTCTACCAGC AGCAGCAGCA GCAGCAACAA
CAACAGCAAC AGCAACAGCT GGCCACAGCC CTGCATCAAC AACAGCTGAT GACTCAGCAG
GCTGCCTTGC AGCAAAAGCC CACTATGGCA GCAGGACAGC AGCCCCAGCC ACAGCCAGCT
GCAGCCCCAC AGCCAGCCCC TGCCCAGGAG CCAGCGATTC AAGCCCCAGT AAGACAACAG
CCAAAGGTTC AGACAACCCC ACCTCCTGCC GTCCAGGGGC AGAAAGTTGG ATCTCTCACT
CCACCCTCAT CCCCCAAAAC CCAACGTGCT GGGCACAGGC GTATTCTCAG TGACGTAACC
CACAGTGCAG TCTTTGGGGT CCCTGCCAGC AAATCAACCC AGCTGCTCCA GGCAGCTGCA
GCTGAGGCCA GTCTCAATAA GTCCAAGTCT GCAACCACCA CTCCATCAGG CTCTCCTCGG
ACCTCTCAAC AAAACGTTTA TAATCCTTCA GAAGGGTCTA CGTGGAATCC CTTTGATGAC
GATAATTTCT CCAAACTCAC AGCTGAAGAA CTGCTAAACA AGGACTTTGC CAAGCTTGGG
GAAGGCAAAC ATCCCGAGAA GCTTGGAGGC TCAGCTGAGA GTTTGATCCC AGGCTTTCAA
TCAACCCAAG GTGATGCTTT TGCTACGACC TCATTTTCTG CTGGAACTGC TGAAAAAAGG
AAGGGTGGGC AGACTGTGGA CTCTGGCCTC CCGCTTCTAA GCGTGTCTGA TCCTTTCATT
CCTCTTCAAG TACCTGATGC ACCAGAAAAA CTAATTGAGG GACTCAAATC TCCTGACACT
TCTCTTCTGC TCCCTGACCT CTTGCCTATG ACAGATCCTT TTGGTAGCAC TTCTGATGCT
GTAATTGAAA AAGCTGATGT TGCTGTTGAG AGTCTCATAC CAGGACTGGA GCCCCCAGTT
CCCCAGCGCC TCCCATCTCA GACGGAATCT GTGACCTCGA ATCGCACAGA TTCTCTCACC
GGGGAAGATT CCCTGCTTGA TTGCTCTCTG CTCTCTAACC CTACTACTGA CCTTCTGGAA
GAGTTTGCCC CCACAGCAAT CTCTGCTCCA GTCCATAAAG CTGCAGAAGA TAGTAATCTC
ATCTCAGGTT TTGATGTCCC TGAGGGCTCG GACAAGGTGG CTGAAGATGA GTTTGACCCT
ATTCCTGTAT TGATAACCAA AAACCCACAA GGTGGGCACT CTAGAAACAG CAGTGGGAGC
TCTGAGTCCA GTCTTCCCAA CCTAGCCAGG TCTTTACTGC TGGTGGATCA GCTCATAGAC
CTGTAG

The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

book

Family-wide Structural Analysis of Human Numb-Associated Protein Kinases.
Structure (London, England : 1993)24(3)401-11(2016 Mar)
Sorrell FJ,Szklarz M,Abdul Azeez KR,Elkins JM,Knapp S


book

Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy.
Science signaling8(371)rs3(2015 Apr)
So J,Pasculescu A,Dai AY,Williton K,James A,Nguyen V,Creixell P,Schoof EM,Sinclair J,Barrios-Rodiles M,Gu J,Krizus A,Williams R,Olhovsky M,Dennis JW,Wrana JL,Linding R,Jorgensen C,Pawson T,Colwill K


book

AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets.
Journal of virology89(8)4387-404(2015 Apr)
Neveu G,Ziv-Av A,Barouch-Bentov R,Berkerman E,Mulholland J,Einav S


book

Genetic variants associated with serum thyroid stimulating hormone (TSH) levels in European Americans and African Americans from the eMERGE Network.
PloS one9(12)e111301(2014)
Malinowski JR,Denny JC,Bielinski SJ,Basford MA,Bradford Y,Peissig PL,Carrell D,Crosslin DR,Pathak J,Rasmussen L,Pacheco J,Kho A,Newton KM,Li R,Kullo IJ,Chute CG,Chisholm RL,Jarvik GP,Larson EB,McCarty CA,Masys DR,Roden DM,de Andrade M,Ritchie MD,Crawford DC


book

Genome-wide association study of a heart failure related metabolomic profile among African Americans in the Atherosclerosis Risk in Communities (ARIC) study.
Genetic epidemiology37(8)840-5(2013 Dec)
Yu B,Zheng Y,Alexander D,Manolio TA,Alonso A,Nettleton JA,Boerwinkle E


 
*
*
*
*